Page last updated: 2024-08-25

isoalantolactone and Asthma, Bronchial

isoalantolactone has been researched along with Asthma, Bronchial in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Li, X; Liu, F; Shen, Y; Song, Y; Zhu, H1

Other Studies

1 other study(ies) available for isoalantolactone and Asthma, Bronchial

ArticleYear
Isoalantolactone alleviates ovalbumin‑induced asthmatic inflammation by reducing alternatively activated macrophage and STAT6/PPAR‑γ/KLF4 signals.
    Molecular medicine reports, 2021, Volume: 24, Issue:4

    Topics: Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Chemokine CCL17; Cytokines; Female; Humans; Immunoglobulin E; Inflammation; Interleukin-4; Kruppel-Like Factor 4; Lipopolysaccharides; Lung; Macrophages; Mice; Mice, Inbred BALB C; Ovalbumin; PPAR gamma; Sesquiterpenes; STAT6 Transcription Factor

2021